CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
0.9305
1.22%
Market Trading Hours* (UTC) Opens on Monday at 07:00

Mon - Fri: 07:00 - 15:30

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
Trading сonditions
Spread 0.0380
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.025288 %
Charges from full value of position ($-4.80)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.025288%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.00337 %
Charges from full value of position ($0.64)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.00337%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency GBP
Margin 5%
Stock exchange United Kingdom of Great Britain and Northern Ireland
Commission on trade 0%

*Information provided by Capital.com

Dr Martens PLC ESG Risk Ratings

High Medium Low Negligible

‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 0.942
Open* 0.9385
1-Year Change* -34.28%
Day's Range* 0.9275 - 0.9605
52 wk Range 0.74-1.75
Average Volume (10 days) 2.49M
Average Volume (3 months) 64.32M
Market Cap 714.45M
P/E Ratio 7.21
Shares Outstanding 961.58M
Revenue 977.50M
EPS 0.10
Dividend (Yield %) 7.86003
Beta -100.00K
Next Earnings Date May 30, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Apr 12, 2024 0.9305 -0.0080 -0.85% 0.9385 0.9630 0.9275
Apr 11, 2024 0.9575 0.0225 2.41% 0.9350 0.9580 0.9160
Apr 10, 2024 0.9480 0.0065 0.69% 0.9415 0.9725 0.9280
Apr 9, 2024 0.9415 0.0020 0.21% 0.9395 0.9865 0.9125
Apr 8, 2024 0.9390 0.0220 2.40% 0.9170 0.9780 0.8990
Apr 5, 2024 0.9225 -0.0340 -3.55% 0.9565 0.9565 0.9130
Apr 4, 2024 0.9565 0.0440 4.82% 0.9125 0.9640 0.9125
Apr 3, 2024 0.9125 0.0110 1.22% 0.9015 0.9270 0.8780
Apr 2, 2024 0.8930 0.0465 5.49% 0.8465 0.9330 0.8460
Mar 28, 2024 0.8725 0.0070 0.81% 0.8655 0.8875 0.8500
Mar 27, 2024 0.8820 0.0565 6.84% 0.8255 0.8900 0.8255
Mar 26, 2024 0.8450 0.0080 0.96% 0.8370 0.8515 0.8090
Mar 25, 2024 0.8765 0.0260 3.06% 0.8505 0.8870 0.8370
Mar 22, 2024 0.8490 -0.0160 -1.85% 0.8650 0.8710 0.8480
Mar 21, 2024 0.8505 -0.0175 -2.02% 0.8680 0.8775 0.8405
Mar 20, 2024 0.8605 0.0080 0.94% 0.8525 0.8765 0.8525
Mar 19, 2024 0.8860 0.0105 1.20% 0.8755 0.9110 0.8755
Mar 18, 2024 0.8905 0.0260 3.01% 0.8645 0.8995 0.8645
Mar 15, 2024 0.8730 -0.0120 -1.36% 0.8850 0.9035 0.8730
Mar 14, 2024 0.9000 0.0135 1.52% 0.8865 0.9265 0.8850

Dr. Martens plc Events

Time (UTC) Country Event
Thursday, May 30, 2024

Time (UTC)

07:30

Country

GB

Event

Full Year 2024 Dr Martens PLC Earnings Release
Full Year 2024 Dr Martens PLC Earnings Release

Forecast

-

Previous

-

Time (UTC)

10:59

Country

GB

Event

Full Year 2024 Dr Martens PLC Earnings Presentation
Full Year 2024 Dr Martens PLC Earnings Presentation

Forecast

-

Previous

-
Friday, July 12, 2024

Time (UTC)

08:30

Country

GB

Event

Dr Martens PLC Annual Shareholders Meeting
Dr Martens PLC Annual Shareholders Meeting

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2023 2022 2021 2020 2019
Total revenue 1000.3 908.3 773 672.2 454.4
Revenue 1000.3 908.3 773 672.2 454.4
Cost of Revenue, Total 382.2 329.5 302.5 270.7 193.8
Gross Profit 618.1 578.8 470.5 401.5 260.6
Total Operating Expense 824.1 679 660.5 529.7 386.4
Selling/General/Admin. Expenses, Total 373.1 315.8 246.3 217 175.6
Depreciation / Amortization 54.2 36.7 33.9 28.9 9.8
Interest Expense (Income) - Net Operating 10.7 -3.2 -3.8 0.5 1.2
Unusual Expense (Income) 3.9 0.2 81.6 12.6 6
Operating Income 176.2 229.3 112.5 142.5 68
Interest Income (Expense), Net Non-Operating -16.8 -15 -41.6 -41.5 -39.1
Net Income Before Taxes 159.4 214.3 70.9 101 28.9
Net Income After Taxes 128.9 181.2 35.7 74.8 17.2
Net Income Before Extra. Items 128.9 181.2 35.7 74.8 17.2
Net Income 128.9 181.2 35.7 74.8 17.2
Income Available to Common Excl. Extra. Items 128.9 181.2 35.7 74.8 17.2
Income Available to Common Incl. Extra. Items 128.9 181.2 35.7 74.8 17.2
Diluted Net Income 128.9 181.2 35.7 74.8 17.2
Diluted Weighted Average Shares 1001.2 1002.9 1000.4 1000 1000
Diluted EPS Excluding Extraordinary Items 0.12875 0.18068 0.03569 0.0748 0.0172
Dividends per Share - Common Stock Primary Issue 0.0584 0.055 0 0
Diluted Normalized EPS 0.1319 0.18084 0.07676 0.08413 0.02077
Mar 2023 Sep 2022 Mar 2022 Sep 2021 Mar 2021
Total revenue 581.7 418.6 538.4 369.9 454.8
Revenue 581.7 418.6 538.4 369.9 454.8
Cost of Revenue, Total 221.4 160.8 186.2 143.3 170.6
Gross Profit 360.3 257.8 352.2 226.6 284.2
Total Operating Expense 470.8 353.3 377.8 301.2 407.1
Selling/General/Admin. Expenses, Total 204.1 169 178 137.8 146.3
Depreciation / Amortization 30.9 23.3 18.7 18 16.6
Interest Expense (Income) - Net Operating 10.5 0.2 -5.3 2.1 -3.9
Unusual Expense (Income) 3.9 0.2 0 77.5
Operating Income 110.9 65.3 160.6 68.7 47.7
Interest Income (Expense), Net Non-Operating -9.4 -7.4 -7.6 -7.4 -18.7
Net Income Before Taxes 101.5 57.9 153 61.3 29
Net Income After Taxes 84.2 44.7 132.6 48.6 6.2
Net Income Before Extra. Items 84.2 44.7 132.6 48.6 6.2
Net Income 84.2 44.7 132.6 48.6 6.2
Income Available to Common Excl. Extra. Items 84.2 44.7 132.6 48.6 6.2
Income Available to Common Incl. Extra. Items 84.2 44.7 132.6 48.6 6.2
Diluted Net Income 84.2 44.7 132.6 48.6 6.2
Diluted Weighted Average Shares 1000.7 1004.7 1003.2 1002.6 1000.8
Diluted EPS Excluding Extraordinary Items 0.08414 0.04449 0.13218 0.04847 0.0062
Dividends per Share - Common Stock Primary Issue 0.0428 0.0156 0.0428
Diluted Normalized EPS 0.08737 0.04449 0.13235 0.04847 0.05653
  • Annual
  • Quarterly
2023 2022 2021 2020 2019
Total Current Assets 508.8 443.6 274.8 277.2 165.5
Cash and Short Term Investments 157.5 228 113.6 117.2 58.4
Cash & Equivalents 157.5 228 113.6 117.2 58.4
Total Receivables, Net 86.3 87.6 56 65 48.9
Accounts Receivable - Trade, Net 78.8 75.9 50.7 55.5 40.8
Total Inventory 257.8 123 101.5 90 53.9
Prepaid Expenses 6.7 4.1 3.4 3.5 4.2
Other Current Assets, Total 0.5 0.9 0.3 1.5 0.1
Total Assets 992.6 859.1 652.8 656.5 450.2
Property/Plant/Equipment, Total - Net 205.4 143.8 110 114.7 26.9
Property/Plant/Equipment, Total - Gross 344.6 239 181.6 159.2 47.6
Accumulated Depreciation, Total -139.2 -95.2 -71.6 -44.5 -20.7
Goodwill, Net 240.7 240.7 240.7 240.7 240.7
Intangibles, Net 24.9 21.4 20.1 16.5 11.1
Other Long Term Assets, Total 12.8 9.6 7.2 7.4 6
Total Current Liabilities 164.5 155 152.3 130.7 64.5
Accounts Payable 64.2 52.4 52.6 33.4 20
Accrued Expenses 57.9 76.8 75.1 50.1 27.6
Notes Payable/Short Term Debt 0 0 0 20 0
Current Port. of LT Debt/Capital Leases 34.1 19.8 18.2 21.8 3.2
Other Current Liabilities, Total 8.3 6 6.4 5.4 13.7
Total Liabilities 588.4 530.9 502.1 586 458.6
Total Long Term Debt 417.7 374 348.2 453.8 387.5
Long Term Debt 293.4 280.9 281.6 387.2 387.5
Capital Lease Obligations 124.3 93.1 66.6 66.6 0
Other Liabilities, Total 4.4 1.9 1.6 1.5 6.6
Total Equity 404.2 328.2 150.7 70.5 -8.4
Common Stock 10 10 10 0 0
Additional Paid-In Capital 0 0
Retained Earnings (Accumulated Deficit) 382.2 311.3 138.1 58.9 -15.9
Treasury Stock - Common 0 0 0
Other Equity, Total 12 6.9 2.6 11.6 7.5
Total Liabilities & Shareholders’ Equity 992.6 859.1 652.8 656.5 450.2
Total Common Shares Outstanding 1000.79 1000.22 1000 1000 1000
Deferred Income Tax 1.8
Mar 2023 Sep 2022 Mar 2022 Sep 2021 Mar 2021
Total Current Assets 508.8 523.6 443.6 314 274.8
Cash and Short Term Investments 157.5 133 228 113.2 113.6
Cash & Equivalents 157.5 133 228 113.2 113.6
Total Receivables, Net 86.3 114.2 87.6 73.9 56
Accounts Receivable - Trade, Net 78.8 95.8 75.9 64.2 50.7
Total Inventory 257.8 261.4 123 119.8 101.5
Prepaid Expenses 6.7 8.5 4.1 6.7 3.4
Other Current Assets, Total 0.5 6.5 0.9 0.4 0.3
Total Assets 992.6 981.3 859.1 709.6 652.8
Property/Plant/Equipment, Total - Net 205.4 181.6 143.8 125.6 110
Property/Plant/Equipment, Total - Gross 344.6 239 212.2 181.6
Accumulated Depreciation, Total -139.2 -95.2 -86.6 -71.6
Goodwill, Net 240.7 240.7 240.7 240.7 240.7
Intangibles, Net 24.9 24.4 21.4 20.6 20.1
Other Long Term Assets, Total 12.8 11 9.6 8.7 7.2
Total Current Liabilities 164.5 218.9 155 140.2 152.3
Accounts Payable 64.2 105.7 52.4 46 52.6
Accrued Expenses 57.9 75.1 76.8 66.8 75.1
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 34.1 28.4 19.8 20 18.2
Other Current Liabilities, Total 8.3 9.7 6 7.4 6.4
Total Liabilities 588.4 634.8 530.9 506 502.1
Total Long Term Debt 417.7 410.6 374 364.1 348.2
Long Term Debt 293.4 292.9 280.9 285.3 281.6
Capital Lease Obligations 124.3 117.7 93.1 78.8 66.6
Other Liabilities, Total 4.4 4.5 1.9 1.7 1.6
Total Equity 404.2 346.5 328.2 203.6 150.7
Common Stock 10 10 10 10 10
Additional Paid-In Capital
Retained Earnings (Accumulated Deficit) 382.2 316.2 311.3 188.6 138.1
Treasury Stock - Common
Other Equity, Total 12 20.3 6.9 5 2.6
Total Liabilities & Shareholders’ Equity 992.6 981.3 859.1 709.6 652.8
Total Common Shares Outstanding 1000.79 1000.56 1000.22 1000 1000
Deferred Income Tax 1.8 0.8
  • Annual
  • Quarterly
2023 2022 2021 2020 2019
Net income/Starting Line 128.9 181.2 35.7 74.8 17.2
Cash From Operating Activities 77.3 184.4 160.2 121.4 56
Cash From Operating Activities 58.1 36.9 35 29.5 10.6
Non-Cash Items 28 17 49.3 42.4 41
Cash Taxes Paid -8.2 8.1 -2.1 8.3 0.4
Cash Interest Paid 12 10.8 12.8 5.4 5.2
Changes in Working Capital -137.7 -50.7 40.2 -25.3 -12.8
Cash From Investing Activities -50.6 -25 -18.6 -21.9 -17.1
Capital Expenditures -51.4 -25 -18.6 -21.9 -17.1
Other Investing Cash Flow Items, Total 0.8 0 0
Cash From Financing Activities -99.5 -47 -132.9 -44 -69.3
Financing Cash Flow Items -12 -10.8 -12.8 -5.4 -5.2
Issuance (Retirement) of Stock, Net 0 -303.6 -35 -60
Issuance (Retirement) of Debt, Net -29.1 -24 183.5 -3.6 -4.1
Foreign Exchange Effects 2.3 2 -12.3 3.3 2.4
Net Change in Cash -70.5 114.4 -3.6 58.8 -28
Total Cash Dividends Paid -58.4 -12.2
Mar 2023 Sep 2022 Mar 2022 Sep 2021 Mar 2021
Net income/Starting Line 128.9 44.7 181.2 48.6 35.7
Cash From Operating Activities 77.3 -22.7 184.4 23.9 160.2
Cash From Operating Activities 58.1 23.3 36.9 18 35
Non-Cash Items 28 10.6 17 11.3 49.3
Cash Taxes Paid -8.2 0.9 8.1 7.9 -2.1
Cash Interest Paid 12 4.2 10.8 4.3 12.8
Changes in Working Capital -137.7 -101.3 -50.7 -54 40.2
Cash From Investing Activities -50.6 -19.3 -25 -10.1 -18.6
Capital Expenditures -51.4 -19.3 -25 -10.1 -18.6
Other Investing Cash Flow Items, Total 0.8 0
Cash From Financing Activities -99.5 -57.6 -47 -15.8 -132.9
Financing Cash Flow Items -12 -4.2 -10.8 -4.3 -12.8
Issuance (Retirement) of Stock, Net 0 0 -303.6
Issuance (Retirement) of Debt, Net -29.1 -10.6 -24 -11.5 183.5
Foreign Exchange Effects 2.3 4.6 2 1.6 -12.3
Net Change in Cash -70.5 -95 114.4 -0.4 -3.6
Total Cash Dividends Paid -58.4 -42.8 -12.2

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Dr. Martens plc Company profile

About Dr Martens PLC

Dr. Martens plc is a United Kingdom-based company that designs, develops, procures, markets, sells and distributes footwear, under the Dr. Martens brand. The Company operates through three reporting segments: Europe, the Middle East and Africa (EMEA), Americas and Americas and Asia-Pacific (APAC). Its product categories include Originals, Fusion, Kids, Casual and Accessories. The Originals category comprises boots, shoes and loafers and also included within the Originals category is the Made in England range. The Fusion category comprises platform boots and shoes, sandals, heels and refined take downs of the Originals. Within the Kids category is the mini-me range, which includes Originals, Fusion and Casual collections. It offers various accessories, such as shoe care, laces and socks, leather bags and small leather items. It operates in over 60 countries globally, through a range of modes: directly operated stores and ecommerce sites, wholesale partners and distributors.

Financial summary

BRIEF: For the six months ended 30 September 2021, Dr Martens PLC revenues increased 16% to £369.9M. Net income increased 65% to £48.6M. Revenues reflect Americas segment increase of 44% to £147.5M, Americas segment increase of 44% to £147.5M, Retail Sales - Total increase of 92% to £65.9M, Online Sales - Total increase of 10% to £82.6M. Net income benefited from Interest expense decrease of 75% to £5.1M (expense). Dividend per share totaled to £0.01.

Industry: Footwear (NEC)

28 Jamestown Rd
Camden
LONDON
NW1 7BY
GB

Income Statement

  • Annual
  • Quarterly

News

US Earnings Season : JP Morgan, Citigroup, Wells Fargo

The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

16:03, 11 April 2024

Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

09:22, 11 April 2024

US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

15:11, 9 April 2024

How escalating geopolitical tensions are impacting oil markets

The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.

13:34, 4 April 2024

A way forward: a roundup of recent central bank decisions

Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.

12:47, 22 March 2024

Bank of Japan Preview: will the BOJ end negative interest rates?

The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

08:44, 18 March 2024

Higher CPI leaves traders unfazed as US equities continue to build momentum

The latest US CPI reading hasn’t gone how the Federal would have hoped. Consumer prices came in higher than expected in February for the third month in a row.

12:42, 15 March 2024

People also watch

ETH/USD

3,161.94 Price
+8.270% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

TSLA

172.44 Price
-0.890% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 0.13

XRP/USD

0.51 Price
+15.880% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

NVDA

880.87 Price
-2.750% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 0.42

Still looking for a broker you can trust?

Join the 610,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading